IDiyas

For the Inventor, By the Inventor

Jacou, France

Christophe Parsy

USPTO Granted Patents = 22 

Average Co-Inventor Count = 5.1

ph-index = 6

Forward Citations = 200(Granted Patents)


Company Filing History:

goldMedal21 out of 100 
 
Idenix Pharmaceuticals, Inc.
 patents
silverMedal3 out of 5,069 
 
Centre National De La Recherche Scientifique
 patents
bronzeMedal2 out of 37 
 
Université Montpellier 2 Sciences Et Techniques
 patents
4. 1 out of 1 
 
Biofocus Dpi, Ltd.
 patent
5. 1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
6. 1 out of 278 
 
Universitè De Montpellier
 patents
where one patent can have more than one assignee

Years Active: 2011-2021

Loading Chart...
22 patents (USPTO):
1. 11040975 - Carbocyclic nucleoside reverse transcriptase inhibitors (2021-06-22),
2. 10766917 - Nucleotides for the treatment of cancer (2020-09-08),
3. 10513534 - 2'-chloro nucleoside analogs for HCV infection (2019-12-24),
4. 10231986 - Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of HCV (2019-03-19),
5. 10030044 - Nucleotides for the treatment of liver cancer (2018-07-24),
6. 9353100 - Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections (2016-05-31),
7. 9309275 - 3'-deoxy nucleosides for the treatment of HCV (2016-04-12),
8. 9296778 - 3',5′-cyclic phosphate prodrugs for HCV infection (2016-03-29),
9. 9284307 - Macrocyclic serine protease inhibitors (2016-03-15),
10. 9187496 - 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors (2015-11-17),
11. 9115095 - Phosphinate ruthenium complexes (2015-08-25),
12. 9109001 - 3',5′-cyclic phosphoramidate prodrugs for HCV infection (2015-08-18),
13. 8993595 - Macrocyclic serine protease inhibitors (2015-03-31),
14. 8765966 - Phosphinate ruthenium complexes (2014-07-01),
15. 8507460 - Substituted 3',5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections (2013-08-13),

Title: Christophe Parsy: A Visionary Inventor Shaping the Future

Introduction:

Christophe Parsy, a passionate inventor hailing from Jacou, FR, is a true pioneer in the world of innovation. With a total of 22 patents to his name, Parsy's relentless pursuit of finding solutions to complex challenges has solidified his position as a frontrunner in technological advancements.

Latest Patents:

In his latest patents, Christophe Parsy has introduced groundbreaking inventions that have the potential to revolutionize the fields of HIV treatment and cancer therapy. His Carbocyclic nucleoside reverse transcriptase inhibitors and Nucleotides for the treatment of cancer showcase his commitment to developing novel compounds for crucial medical treatments.

Career Highlights:

Having worked at esteemed companies such as Idenix Pharmaceuticals, Inc. and the Centre National De La Recherche Scientifique, Parsy has honed his skills and expertise in the realm of pharmaceutical research and development. His innovative approach to problem-solving has paved the way for significant advancements in the industry.

Collaborations:

Throughout his career, Christophe Parsy has collaborated with notable experts in the field, including Dominique Surleraux and Francois-Rene Alexandre. These partnerships have not only enriched his projects but have also led to the creation of impactful solutions that benefit society at large.

Conclusion:

In conclusion, Christophe Parsy's unwavering dedication to innovation and his remarkable contributions to the world of inventions make him a standout figure in the realm of inventors. His work continues to inspire and shape the future of technological advancements, leaving a lasting impact on the industry and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…